OTCMKTS:DNAG DNAPrint Genomics (DNAG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About DNAPrint Genomics Stock (OTCMKTS:DNAG) Get DNAPrint Genomics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume50 shsAverage Volume505,026 shsMarket Capitalization$130 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview DNAPrint Genomics, Inc. was a biotechnology company that developed DNA-based testing technologies for ancestry, ethnicity and human identification. Its work focused on analyzing genetic markers to estimate an individual’s biogeographical ancestry and selected physical traits. The company’s best-known offerings included AncestryByDNA, a consumer-oriented ancestry testing service, and DNAWitness, a forensic application designed to help investigators develop appearance and ancestry profiles from biological evidence. DNAPrint Genomics also pursued additional applications of genetic analysis in areas including personalized medicine and disease research. The company was headquartered in Sarasota, Florida, and operated primarily in the United States. Publicly available information about its current operations, leadership and business activities is limited; the description above reflects its historical activities as a genomics and genetic-testing developer.AI Generated. May Contain Errors. Read More Receive DNAG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DNAPrint Genomics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DNAG Stock News HeadlinesNucleus Genomics CEO explains how "genetic optimization" tools help parents select traits they desire in babiesDecember 3, 2025 | cbsnews.comComparing DNA language models to guide optimal AI selection for genomicsDecember 2, 2025 | msn.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 24 at 1:00 AM | Profits Run (Ad)Uptake of DNA fragments from dying cells could redefine mammalian evolution and genomicsSeptember 26, 2025 | msn.comGenetics testing startup Nucleus Genomics criticized for its embryo product: ‘Makes me so nauseous’June 7, 2025 | msn.comThe Accelerating Pace Of Genomics Technologies For Plants And AnimalsFebruary 5, 2025 | forbes.comAI model learns generalized 'language' of regulatory genomics, predicts cellular storiesJanuary 30, 2025 | msn.comControversial genetics testing startup Nucleus Genomics raises $14M Series AJanuary 30, 2025 | msn.comSee More Headlines DNAG Stock Analysis - Frequently Asked Questions How do I buy shares of DNAPrint Genomics? Shares of DNAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DNAPrint Genomics own? Based on aggregate information from My MarketBeat watchlists, some other companies that DNAPrint Genomics investors own include Editas Medicine (EDIT), Pacira BioSciences (PCRX), BioStem Technologies (BSEM), Berkshire Hathaway (BRK.B), Bristol Myers Squibb (BMY), Bitwise Crypto Industry Innovators ETF (BITQ) and Black Diamond Therapeutics (BDTX). Company Calendar Today9/24/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:DNAG CIKN/A Webwww.dnaprint.com Phone(941) 366-3400Fax941-952-9770Employees24Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,294,790,000Free FloatN/AMarket Cap$130 thousand OptionableNot Optionable BetaN/A The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:DNAG) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...Behind the Markets | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DNAPrint Genomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DNAPrint Genomics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNAG Stock Alerts